Taxol Related Clinical Trials
Comparison of Liposome Entrapped Paclitaxel Easy to Use (LEP-ETU) and Taxol® Pharmacokinetics in Patients With Advanced Cancer [Active, not recruiting]
Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors [Active, not recruiting]
Study of Dose-Dense Adriamycin Plus Cytoxan (AC) Followed by Either Abraxane or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer [Active, not recruiting]
ABI-007 in Taxol Resistant Patients With Metastatic Breast Cancer [Completed]
Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer [Active, not recruiting]
Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer [Completed]
Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer [Completed]
Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel vs Taxol(R) for Treatment of Metastatic Breast Cancer [Terminated]
Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent Restenosis [Active, not recruiting]
Gemcitabine (GEMZAR) Plus ABI-007 (ABRAXANE)In Patients With Advanced Metastatic Pancreatic Cancer [Recruiting]
Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer [Active, not recruiting]
Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer [Active, not recruiting]
Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients [Completed]
Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy [Completed]
Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals [Completed]
Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim Followed by Radiotherapy and Paclitaxel/Carboplatin/ZD1839 in Locally Advanced Unresectable Stage IIIA/B Non-Small Cell Carcinoma of the Lung [Completed]
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer [Active, not recruiting]
Taxol(Paclitaxel),UFT and Leucovorin in Patients With Advanced Gastric Cancer [Completed]
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors [Active, not recruiting]
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer [Completed]
Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer [Active, not recruiting]
Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer [Active, not recruiting]
Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel
Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric Cancers [Completed]
Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer [Recruiting]
Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer [Active, not recruiting]
A Three Arm Study of Adriamycin, Cyclophosphamide Plus Docetaxel vs Adriamycin Plus Cyclophosphamide Followed By Paclitaxel vs Adriamycin Plus Cyclophosphamide Followed By Paclitaxel and Gemcitabine in Adjuvant Breast Cancer [Active, not recruiting]
Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Active, not recruiting]
Weekly Paclitaxel Plus Gemcitabine as Second-Line in Small Cell Lung Cancer [Recruiting]
Phase I/II Study of IV Estramustine Combined With Taxol in Patients With Hormone Refractory Adenocarcinoma of the Prostate [Terminated]
Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel [Active, not recruiting]
Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer [Active, not recruiting]
Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer [Recruiting]
Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) [Recruiting]
Hepatic Arterial Infusion (HAI) of Abraxane [Recruiting]
Phase I & II Trial of Intravesicular Abraxane for Treatment-Refractory Bladder Cancer [Recruiting]
Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma [Recruiting]
Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix [Recruiting]
Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis [Recruiting]
A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck Cancer [Recruiting]
Sutent + Taxol for Advanced Esophageal Cancer [Recruiting]
Pazopanib Plus Paclitaxel (TAXOL) And Pazopanib Plus Paclitaxel(TAXOL) Plus Carboplatin (PARAPLATIN) [Recruiting]
PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer [Recruiting]
A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers [Recruiting]
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab [Recruiting]
A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer [Recruiting]
Phase 1b Study to Evaluate the Safety of AMG 706 in Combination With Paclitaxel or Docetaxel as Treatment for Locally Breast Cancer [Recruiting]
A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer [Recruiting]
Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement [Recruiting]
Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer [Recruiting]
Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer [Recruiting]
A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Cancer [Recruiting]
Safety Study of XL147 in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors [Recruiting]
Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin [Recruiting]
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC [Recruiting]
A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic Melanoma [Recruiting]
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer [Recruiting]
Bevacizumab and Abraxane as Second-Line Therapy in Triple Negative Metastatic Breast Cancer [Recruiting]
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers [Recruiting]
Pharmacokinetics Study of Liposomal Paclitaxel in Humans [Recruiting]
Phase II Lapatinib Plus Nab-Paclitaxel As First And Second Line Therapy In her2+ MBC [Recruiting]
Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxaneâ„¢) [Recruiting]
Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Recruiting]
Carboplatin Plus Docetaxel, Paclitaxel and Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) [Recruiting]
Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus [Recruiting]
Efficacy Study of Endoscopic Ultrasonography (EUS)-Guided Ethanol Lavage With Paclitaxel Injection for Cystic Tumors of the Pancreas [Recruiting]
Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Recruiting]
Patients With Advanced Non-Small Cell Lung Cancer [Recruiting]
A Phase 1b/2a, Open-Label, Multi-Center Study of AV-951 in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer [Not yet recruiting]
Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer [Recruiting]
Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer [Not yet recruiting]
Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer [Recruiting]
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) [Recruiting]
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer [Recruiting]
Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3) [Recruiting]
Abraxane and Temodar Plus Genasense in Advanced Melanoma [Recruiting]
Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer [Recruiting]
Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma [Recruiting]
Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) [Recruiting]
Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma [Recruiting]
Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer [Recruiting]
Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer [Not yet recruiting]
Trial of PTK787/ZK 222584 Plus Paclitaxel [Recruiting]
A Study to Assess the Effectiveness of the Combination of Carboplatin, Paclitaxel, Bevacizumab and Combretastatin (CA4P) in Patients With Chemotherapy Naïve Lung Cancer [Recruiting]
PEPCAD IV, Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients [Recruiting]
Study of Intraperitoneal Nanoparticle Paclitaxel in Patients With Peritoneal Malignancies [Recruiting]
Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients [Recruiting]
Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib [Recruiting]
Papillary Serous Carcinoma of the Endometrium [Recruiting]
BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
|
